Reports and Data

Cerebrospinal Fluid (CSF) Management Market Globally Grow at a CAGR of 4.7% by Revenue During the Period 2021-2028 : Dispomedica, Sophysa, Spiegelberg, Etc

Cerebrospinal Fluid (CSF) Management Market Size – USD 1.45 billion in 2018, Market Growth - CAGR of 4.7%, Market Trends –Tremendous rise in the procedures of shunting and the increase in population of geriatric globally.

 

New York, NY -- (SBWIRE) -- 03/12/2021 -- The Cerebrospinal Fluid Management Market was valued at USD 1.45 Billion in 2018 and is expected to reach USD 2.11 Billion by 2026, at a CAGR of 4.7% during the forecast period. The increase in investment in research and development in the field of cerebrospinal fluid management and increasing geriatric population worldwide are key factors driving the growth of the market for managing cerebrospinal fluids. The growth of the CSF management market is driven by factors such as the high hydrocephalus prevalence and subsequent increase in the number of shunting procedures and increased geriatric population.

Worldwide, there is a significant shortage of neurophysicists and neurochirurgists. With the fast - growing aging population, the current number of neurochirurgists is insufficient to meet the demand for health care.

Top Players Covered in the Report Include:
Dispomedica
Sophysa
Spiegelberg GmbH
Medtronic plc
Integra LifeSciences
Braun
DePuy Synthes
Argi Grup
Moller Medical
Sophysa
Others

One of the biggest limitations is the inability to produce in the required amount of time a sufficient number of trained neurosurgeons. This lack of trained neurochirurgical professionals extends to North America, Europe, Asia Pacific, Latin America, and Africa.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1224

Further key findings from the report suggest:
The Cerebrospinal Fluid Management market was valued at USD 1.45 Billion in 2018 and is expected to reach USD 2.11 Billion by 2026, at a CAGR of 4.7% during the forecast period. The increase in investment in research and development in the field of cerebrospinal fluid management and increasing geriatric population worldwide are key factors driving the growth of the market for managing cerebrospinal fluids.

The market for hospitals is expected to grow the largest and is estimated to reach at USD 781.5 Million in 2026, at a CAGR of 5.4%, owing to large number of in-hospital cases related to cerebrospinal fluid management in elderly population. The market for Ambulatory Surgical Centers and Diagnostic Centers is expected to grow at the highest CAGR of 6.1% during the forecast period owing to the low cost in relation with surgery in the facility.

The market for shunts is estimated to reach USD 1065.1 Million in 2026, at a CAGR of 7.2%, during the forecast period. The increasing growth in the shunts market can be attributed primarily to the increasing number of worldwide shunting procedures and the increasing number of revision shunt surgeries.

The market for pediatric is expected to reach USD 663.6 Million in 2026, at a CAGR of 5.8% during the forecast period. This can be attributed primarily to the high prevalence of congenital hydrocephalus in the pediatric population along with the increasing number of shunting procedures.

The market for Asia Pacific (APAC) is expected to reach USD 634.7 Million in 2026, at a CAGR of 6.6%. Developing economies like Russia, India, Brazil, China, and South Africa are among the fastest growing hydrocephalus-based economies in the world. It is expected that the presence of such a huge patient base in this region, along with rising healthcare spending, will serve as an opportunity for players in the CSF management market.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1224

Segments covered in the report:
This report forecasts volume and revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the market on the basis of types, end use, patient type and regional analysis.

Types (Revenue, USD Million; 2016-2026)
Shunts
Ventriculoperitoneal Shunts
Ventriculoatrial Shunts
Lumboperitoneal Shunts
Ventriculopleural Shunts
Fixed Valve Shunts
Adjustable Valve Shunts
External Drainage Systems
External Ventricular Drainage Systems
Lumbar Drainage Systems

End Use (Revenue, USD Million; 2016-2026)
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Patient Type (Revenue, USD Million; 2016-2026)
Pediatric
Adult
Geriatric

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/cerebrospinal-fluid-csf-management-market

Region (Thousand, Units and Revenue, USD Million; 2016-2026)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of the Europe
Asia Pacific
China
India
Japan
Rest of Asia Pacific
Latin America
Brazil
Rest of LATAM
Middle East & Africa

The report offers:
An in-depth overview of the Cerebrospinal Fluid (CSF) Management market landscape
Assessment of the global industry trends for the historical period of 2017-2018, the current year 2019-2020, and a forecast estimation for the period 2020-2027
Overview of the company profiles and product portfolios
R&D advancements and technological developments in the global Cerebrospinal Fluid (CSF) Management industry
Market dynamics, trends, opportunities, and risks
Study of the market in terms of revenue and product consumption patterns

Thank you for reading our report. For further information or query regarding the report or its customization, please connect with us. Our team will ensure you get a report well-suited to your needs.

Table of contents:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018-2026

Chapter 3. Indicative Metrics

Chapter 4. Cerebrospinal Fluid Management Segmentation & Impact Analysis
4.1. Cerebrospinal Fluid Management Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. High hydrocephalus prevalence and subsequent increase in shunting procedures
4.2.2.2. Growing Geriatric Population
4.2.2.3. Favorable Insurance scenario
4.2.3. Market restraints analysis
4.2.3.1. Lack of skilled professionals & infrastructure in emerging markets
4.2.3.2. High associated costs
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter's Five Forces Analysis
4.7. Competitive Metric Space Analysis

Chapter 5. Cerebrospinal Fluid Management Market By Types Insights & Trends
5.1. Diseases dynamics & Market Share, 2018 & 2026
5.2. Osteoarthritis Shunts
5.2.1. Market estimates and forecast, 2016 – 2026 (USD Million)
5.2.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
5.2.3. Ventriculoperitoneal Shunts
5.2.4. Ventriculoatrial Shunts
5.2.5. Lumboperitoneal Shunts
5.2.6. Ventriculopleural Shunts
5.2.7. Fixed Valve Shunts
5.2.8. Adjustable Valve Shunts
5.3. External Drainage Systems
5.3.1. Market estimates and forecast, 2016 – 2026 (USD Million)
5.3.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
5.3.3. External Ventricular Drainage Systems
5.3.4. Lumbar Drainage Systems

Chapter 6. Cerebrospinal Fluid Management Market By End Use Insights & Trends

Continued…..